Why the study?
Does blood pressure lowering with perindopril and indapamide therapy reduce dementia and cognitive decline in patients with cerebrovascular disease?
Does blood pressure lowering with perindopril and indapamide therapy reduce dementia and cognitive decline in patients with cerebrovascular disease?
Blood pressure lowering with perindopril and indapamide reduces the risk of dementia and cognitive decline in patients with cerebrovascular disease.
Supports BP lowering in cerebrovascular disease to curb dementia; extends stroke-prevention data to cognitive outcomes.
Active treatment was associated with reduced risks of dementia and cognitive decline associated with recurrent stroke. These findings further support the recommendation that blood pressure lowering with perindopril and indapamide therapy be considered for all patients with cerebrovascular disease.
No takes yet. Share an insight, caveat, or question.
Christophe Tzourio (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: